Skip to main content
. 2020 Jun 1;23(2):93–102. doi: 10.14475/kjhpc.2020.23.2.93

Table 3.

Comparison of Various Factors according to Whether the Patient or the Patient’s Family Made the Decision to Provide Consent to Withdraw Life-Sustaining Treatment (N=334).

Variables Patient decision (N=115) Family decision (N=219) P-value


n(%) or Mean±SD n(%) or Mean±SD
Sex 0.246
Male 68 (59.1) 145 (66.2)
Female 47 (40.9) 74 (33.8)
Age (yr) 63.9±10.4 69.9±12.8 <0.001
Place where consent for withholding life-sustaining treatment was provided <0.001
General ward 99 (86.1) 84 (38.4)
Intensive care unit 9 (7.8) 95 (43.4)
Emergency room 7 (6.1) 40 (18.3)
Survival or location of death 0.061
Survival 6 (5.2) 21 (9.6)
Death at our hospital 87 (75.7) 174 (79.5)
Death at other place 22 (19.1) 24 (11.1)
Duration of hospitalization (days)
Admission to consent for withholding of life-sustaining treatment 11.7±14.2 14.2±21.7 0.204
Consent for withholding life-sustaining treatment to death 28.7±41.3 10.5±23.2 <0.001
Types of patients <0.001
End stage of life patients 9 (7.8) 78 (35.6)
Terminal patients 106 (92.2) 141 (64.4)
Special life-sustaining treatments mentioned in the consent form (multiple responses)
Cardiac resuscitation 115 (100) 218 (99.5) 1
Intubation and ventilator care 111 (96.5) 156 (71.2) <0.001
Hemodialysis 111 (96.5) 164 (74.9) <0.001
Chemotherapy 102 (88.7) 190 (86.8) 0.739
Intensive end of life care before provision of consent for withholding life-sustaining treatment
Done 21 (18.3) 146 (66.7) <0.001

Values are presented as mean±standard deviation or number (%).